CClinicalTrials.gg
Status unknownNCT04438200GVASUpdated Jun 18, 2020

Liver and Bone Retinol Levels in Guatemalan Adolescents and Adults

An observational study in Vitamin A Deficiency, Vitamin A Toxicity and Hypervitaminosis A, sponsored by Newcastle University. Status unknown at 5 sites in 2 countries. Open to participants aged 10 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-06-18.

Sponsored by Newcastle University · Observational

The sponsor has not verified this record recently (last verified Feb 2020), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
150
Ages
10 Years and older
Sex
All
01

Study summary

Guatemala has enforced mandatory fortification of sugar with vitamin A (VA) since June 1974 and has led to a highly successful reduction in VA deficiency and associated disease. However, Ribaya-Mercado et al. 2014, estimated the biological impact of sugar fortified with retinyl palmitate that there may be a risk of chronic excess intake of preformed VA associated with programs of mass fortification. A recent food consumption survey in two departments in Guatemala found the average daily sugar intake in children under the age of two who aren´t being breastfed is 30.3 g, which translates into a daily intake of 272 μg of retinol (almost the full estimated average requirement (EAR) for that age group). Since data from the second National Survey on Micronutrients suggest a risk of VA toxicity, it is important to determine the levels of hepatic VA directly in corpses of individuals, of all ages, who have died of non-metabolic causes. Due to this, the investigators propose to assess liver and bone VA levels in combination with gene expression, histopathology and biochemical analyses, to elicit indications of hypervitaminosis A in Guatemala.

Read the detailed description

Objectives:

  1. To determine the post mortem concentration of hepatic and bone VA in corpses of adolescent, young and elderly adults as an indicator of exposure to dietary VA
  2. To assess the effect of high VA exposure on key enzymes in liver and bone tissue and to assess the risk of hypervitaminosis A in people exposed to compulsory mass vitamin A fortification program in Guatemala.

Methodology:

Setting and sampling The corpses for this study will be obtained from the National Institute of Forensic Sciences' (INACIF) departmental morgues in 2 hospitals in Guatemala City. The study population will be 150 cadavers sampled for VA tissue concentration; gene expression analysis combined with histopathology.

Sample collection process and duration All samples will be collected during necropsies carried out at the INACIF forensic morgue. During necropsy, the liver will be weighed and the information recorded. A range of up to 10 x 3 g samples of the liver's right lobe will be obtained. Each sample will be properly labelled with previously prepared codes. Liver samples for histopathological analysis will be stored in 10% buffered formalin for 24 hours prior to transfer to ethanol before embedding, sectioning and staining. All samples collected for retinoid analysis will be frozen on dry ice in the morgue, transported as such to the laboratory and subsequently stored at -80˚C. Liver samples for gene expression analysis will be collected in RNAlater solution to protect RNA stability and subsequently stored at -80˚C until shipment to Newcastle University. The hepatic VA analysis will be done in Newcastle University using established High Perfromance Liquid Chromatography (HPLC) methods. Samples for analysis of gene expression will be sent on dry ice to Newcastle for RNA extraction and quantification. Since it is possible to obtain good quality RNA suitable for Quantitative Polymerase Chain Reaction (q-PCR) based analyses from post mortem tissue up to 72 hours after death, tissue samples stored in RNAlater within 24 hours of death will be adequate for gene expression analysis. Furthermore, experience from the investigators human biobank in Newcastle shows that tissue RNA can be extracted successfully after the demise of a patient up to 72 hours after death as long as the tissue has a pH of over 6. Gene expression of key regulatory proteins, such as LRAT and CYP26A1 will be performed in Newcastle. Choice of genes was based on the fact that LRAT may become saturated at very high levels of VA, leading to increasing levels of free circulating VA that can be metabolized to retinoic acid and other metabolites via CYP26A. Histopathological analysis will be carried out by pathologists in Guatemala with digitised slides being sent to the pathologist within Newcastle University - these slides will be analysed by both pathologists independently.

Bone samples will also be obtained during the necropsy carried out at the INACIF forensic morgue. The iliac crest bone will be exposed by making an incision and removing the overlying soft tissue (skin, adipose tissue, connective tissue and muscle). The periosteum and cortical bone shall be removed via osteotomy exposing the spongy bone. Biopsy needles will be used to take samples from the spongy bone for analysis of tissue VA concentrations and gene expression, as previously described, at Newcastle University.

All samples will be shipped to Newcastle University on dry ice.

Study duration According to the information provided by INACIF 18 autopsies were performed between March and May 2013 on children less than one year of age, 24 on children from 1 to 4 years old, 11 on children 5 to 9 years old, 51 on individuals from 10 to 14 years old, 281 on adolescents 15 to 19 years old, and 401 on young adults 20 to 24 years old. According to INACIF's forensic doctor, \~60% of the total number of autopsies carried out in Guatemala are performed in the capital city. The main causes of death in children under the age of 9 were head injuries and other types of trauma. Individuals from 10 to 24 years of age died mainly due to violence: firearms, stabbings, choking and different types of trauma.

02

Conditions studied

  • Vitamin A Deficiency
  • Vitamin A Toxicity
  • Hypervitaminosis A

Keywords

  • Retinol
  • Hypervitaminosis A
  • Hepatic Vitamin A
  • Guatemala
03

Who can participate

Ages eligible
10 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Guatemalan cadavers, from 2 hospitals in Guatemala City, aged >10 years with a non-metabolic cause of death, within 24 hours of death

Inclusion criteria

  • Aged >10 years
  • Non-metabolic cause of death (e.g. accidents, trauma, or violence from firearms, stabbings, cranial and other trauma, asphyxiation etc.)
  • No longer than 24 hours since the time of death
  • Lived in Guatemala (exposure to fortified sugar)

Exclusion criteria

Exclusion Criteria:

  • Aged \<10 years
  • Individuals with metabolic or nutritional conditions (diabetes, dyslipidemias, chronic alcoholism, etc.)
  • Longer than 24 hours since the time of death
  • Not Guatemalan resident (Tourist, visitor etc.)
04

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
150 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Adolescents

    Individuals aged 10-19 years

  • Young Adults

    Individuals aged 20-39 years

  • Elderly Adults

    Individuals aged 40+ years

05

What researchers measure

Primary outcomes

  1. Liver Vitamin A concentration

    Liver Vitamin A concentration

    Time frame: Enrolment

  2. Liver Gene Expression

    Gene expression associated with Vitamin A

    Time frame: Enrolment

  3. Liver Histology

    Histological changes associated with Vitamin A

    Time frame: Enrolment

  4. Bone Gene Expression

    Gene expression associated with Vitamin A

    Time frame: Enrolment

Secondary outcomes

  1. Bone Vitamin A concentration

    Bone Vitamin A concentration

    Time frame: Enrolment

06

Study locations

4 of 5 sites recruiting
  • Hospital Roosevelt
    Guatemala City, Zona 11, Guatemala
    • Keyla Castellanos, MD · Contact · knca9510@gmail.com
    • Francisco Chew, MD · Contact · chewf5@gmail.com
    • Francisco Chew, MD · Principal investigator
    • Keyla Castellanos, MD · Sub investigator
    Recruiting
  • INCAP
    Guatemala City, Zona 11, Guatemala
    • Francisco Chew, MD · Contact · chewf5@gmail.com
    • Keyla Castellanos, MD · Contact · knca9510@gmail.com
    • Francisco Chew, MD · Principal investigator
    • Keyla Castellanos, MD · Sub investigator
    Recruiting
  • Hospital General San Juan de Dios
    Guatemala City, Zona 1, Guatemala
    • Keyla Castellanos, MD · Contact · knca9510@gmail.com
    • Francisco Chew, MD · Contact · chewf5@gmail.com
    • Francisco Chew, MD · Principal investigator
    • Keyla Castellanos, MD · Sub investigator
    Recruiting
  • Morgue del INACIF
    Guatemala City, Zona 3, Guatemala
    • Keyla Castellanos, MD · Contact · knca9510@gmail.com
    • Francisco Chew, MD · Contact · chewf5@gmail.com
    • Francisco Chew, MD · Principal investigator
    • Keyla Castellanos, MD · Sub investigator
    Recruiting
  • Newcastle University
    Newcastle Upon Tyne, Tyne And Wear NE2 4HH, United Kingdom
    Active, not recruiting
07

References and documents

Publications

  • Pineda, O. (1998). Fortification of Sugar with Vitamin A. Food and Nutrition Bulletin, 19(2), 131-136.
  • Ribaya-Mercado JD, Solomons NW, Medrano Y, Bulux J, Dolnikowski GG, Russell RM, Wallace CB. Use of the deuterated-retinol-dilution technique to monitor the vitamin A status of Nicaraguan schoolchildren 1 y after initiation of the Nicaraguan national program of sugar fortification with vitamin A. Am J Clin Nutr. 2004 Nov;80(5):1291-8. doi: 10.1093/ajcn/80.5.1291. PubMed 15531678 ↗
  • Olsen K, Suri DJ, Davis C, Sheftel J, Nishimoto K, Yamaoka Y, Toya Y, Welham NV, Tanumihardjo SA. Serum retinyl esters are positively correlated with analyzed total liver vitamin A reserves collected from US adults at time of death. Am J Clin Nutr. 2018 Nov 1;108(5):997-1005. doi: 10.1093/ajcn/nqy190. PubMed 30475970 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT04438200
Lead sponsor
Newcastle University
Collaborators
Bill and Melinda Gates Foundation, HarvestPlus, Institute of Nutrition of Central America and Panama, INACIF
Responsible party
Sponsor
First posted
Jun 18, 2020
Start date
Oct 24, 2019
Primary completion
Jul 2020 (estimated)
Completion
Jul 2020 (estimated)
Last update
Jun 18, 2020

Study contacts

Georg Lietz, PhD
Contact
georg.lietz@newcastle.ac.uk
00441912086893
Kieran Finney, BSc (Hons).
Contact
kieran.finney@newcastle.ac.uk
00441912081403
Francisco Chew, MD
principal investigator · Institute of Nutrition of Central America and Panama
Erick Boy, MD, PhD
principal investigator · HarvestPlus
Georg Lietz, PhD
study director · Newcastle University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion